Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05309668
Title Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged >/=1 to <7 Years With NF1-related Symptomatic, Inoperable PN (SPRINKLE)
Acronym SPRINKLE
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: child
Covered Countries USA | NLD | ITA | ESP | DEU

Facility Status City State Zip Country Details
Research Site Akron Ohio 44308 United States Details
Research Site Philadelphia Pennsylvania 19104 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Richmond Virginia 23219 United States Details
Research Site Hamburg 20246 Germany Details
Research Site Munchen 80337 Germany Details
Research Site Tubingen 72076 Germany Details
Research Site Milan 20133 Italy Details
Research Site Rome 00165 Italy Details
Research Site Nagoya 466-8560 Japan Details
Research Site Setagaya 157-8535 Japan Details
Research Site Rotterdam 3015 GD Netherlands Details
Research Site Moscow 119620 Russian Federation Details
Research Site Moscow 125412 Russian Federation Details
Research Site Barcelona 08950 Spain Details
Research Site Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field